Seattle biotech startup Deverra Therapeutics raising cash to develop cellular immunotherapies
GeekWire
SEPTEMBER 19, 2023
Colleen Delaney, the founder, chief scientific officer, and executive vice president of research and development at Deverra Therapeutics. Fred Hutch Photo) Seattle biotech company Deverra Therapeutics is raising cash for its cellular immunotherapies platform that helps doctors treat patients with cancer and other infectious diseases.
Let's personalize your content